What signs of complications or graft failure should a patient monitor for after a facial skin graft while wearing a bolster?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Monitoring a Facial Skin Graft While Wearing a Bolster

Patients should immediately seek medical attention if they notice increasing pain, foul odor, purulent drainage, fever, or progressive swelling around the graft site, as these are cardinal signs of graft infection that can lead to complete graft failure. 1

Critical Warning Signs of Graft Complications

Signs of Infection (Most Important)

  • Purulent or malodorous drainage from beneath or around the bolster indicates bacterial contamination and requires immediate evaluation 1
  • Increasing pain beyond the first 2-3 days, rather than improving pain, suggests infection or graft failure 1
  • Fever or systemic symptoms developing after the procedure warrant urgent assessment 2
  • Foul smell emanating from the dressing is a red flag for anaerobic infection or tissue necrosis 2

Signs of Graft Failure

  • Progressive swelling and redness extending beyond the graft margins after 2-3 days indicates potential graft infection or rejection 1, 3
  • Visible skin color changes such as darkening, dusky appearance, or black discoloration of visible graft edges suggest vascular compromise and necrosis 3
  • Fluid accumulation creating a boggy feeling under the bolster may indicate seroma or hematoma formation, which can compromise graft take 4

Normal vs. Abnormal Findings

Expected Normal Findings

  • Mild discomfort that gradually improves over the first few days is normal 1
  • Some swelling and redness immediately adjacent to the graft site in the first 48-72 hours is expected 1
  • Light serosanguinous drainage (clear to slightly blood-tinged) in small amounts is acceptable 2

Abnormal Findings Requiring Immediate Attention

  • Erythema extending >5 cm from the wound edge with induration mandates immediate evaluation 1
  • Any tissue necrosis visible at graft edges requires urgent intervention 1
  • Persistent tenderness at 2 weeks post-operatively represents true surgical site infection rather than normal inflammation 1

What Patients Can Physically Check

While the bolster limits direct visualization, patients should monitor:

  • Temperature changes: Increasing warmth around the graft site suggests inflammation or infection 1
  • Drainage on outer dressing: Note color, amount, and odor of any fluid soaking through 1
  • Pain level: Use a pain scale daily; pain should decrease, not increase 2
  • Systemic symptoms: Monitor for fever, chills, or malaise 2

Timeline for Concern

  • Days 1-3: Mild pain, swelling, and serosanguinous drainage are normal 1
  • Days 4-7: Symptoms should be improving; worsening at this point suggests infection 1
  • Day 14 and beyond: Persistent swelling, redness, and tenderness indicate true infection 1

Critical Pitfalls to Avoid

  • Delaying evaluation when warning signs appear can lead to complete graft loss, as early intervention is crucial for salvaging infected grafts 1
  • Assuming all drainage is normal: Purulent or foul-smelling discharge always requires immediate assessment 1
  • Ignoring increasing pain: Pain that worsens after day 3-4 is never normal and suggests complications 1
  • Waiting for scheduled follow-up when red flags are present can result in irreversible graft failure 1

When to Contact Your Surgeon Immediately

Contact your surgeon without delay if you experience:

  • Fever >38°C (100.4°F) 2
  • Foul odor from the dressing 2
  • Purulent (thick, yellow, or green) drainage 1
  • Pain that is worsening rather than improving 1
  • Visible darkening or black discoloration of graft edges 3
  • Excessive swelling that continues to increase after day 3 1

References

Guideline

Management of Persistent Periauricular Tag Removal Site Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What are the risks and complications associated with bolster use and how can they be minimized?
What is a bolster dressing on a skin graft?
What is the usual duration before the first dressing change and management protocol for the bolter (bolster) dressing technique on skin grafts?
Is a second treatment of fat grafting to the bilateral feet and face of a 50-year-old female patient with a history of scleroderma and secondary Sjogren's syndrome, who has failed conservative treatments and has significant symptoms, considered medically necessary and eligible for coverage under the HMO plan?
What methods and materials are recommended to secure a skin substitute graft in patients with a history of bleeding disorders or taking anticoagulant medications?
What strategies should be prioritized in a national prevention and control of blindness program for a general population, including vulnerable groups such as children, low-income individuals, and those with limited access to healthcare, to reduce the prevalence of avoidable blindness from eye diseases like cataracts, glaucoma, and diabetic retinopathy?
Is looser scrotal skin a common consequence of atrophied testicles?
Why do I experience lightheadedness after engaging in light physical activity and exposure to cold?
What is the recommended screening process for an elderly individual with concerns about cognitive decline and potential dementia?
What are the initial ventilator settings for a patient post-cardiopulmonary resuscitation (CPR) with potential respiratory failure and possible chronic obstructive pulmonary disease (COPD)?
Is 40mg of Kenalog (triamcinolone) a suitable first-line treatment for a patient with an acute gout flare?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.